• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Comparative study of serum magnesium levels between low dose mgso4and Pritchard regimen in treatment of eclampsia

    Dr.PeruguSravani,Dr. MahitaRaniKatasani,Dr. K. Sharada

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 736-741

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

tonicclonicconvulsionsunrelatedtoothermedicalconditionsinwomenwithhypertensivedisorderof
pregnancy.Although10%ofpregnanciesarecomplicatedbyhypertensivedisorders,eclampsia
continuesto occur in 0.8% of women with hypertensivedisorders.
Objectives:TocomparetheserummagnesiumlevelsinPritchardregimenandlowdose
MgSO4regimen. To compare the maternaland fetalcomplicationsin both groups.
MaterialandMethods:ThisisaProspectivestudyconductedintheDepartmentofObstetrics
andGynaecologyatTertiarycareteachinghospitaloveraperiodof1yearoneclampticpatients
whogotadmittedindepartmentofobstetricsandgynecology.Standardprinciplesof
managementofeclampsiawillbefollowed.Patientsaredividedintotwogroupsascases&
controlalternatively.Groupsarechosenbasedoninclusion&exclusioncriteria.GroupI
ControlwillfollowPritchardstandardregimen.GroupIICaseswillreceivelowdose
magnesiumsulphateregimen.
Conclusion:Theoccurrenceofeclampsiaintwogroupswasmorecommonintheagerange of 20 to
26yearsamongtheprimigravidaand with previoushistory ofPIH. Thereisnomajor
differenceintheoutcomeofmaternalandfetalinbothgroups.Nonethelessthemagnesium
levelsamonglowdosegrouparesignificantlylowerincomparisonwithstandardregimen group. In
casesand controlsthe magnesium levelsare maintained in normal therapeuticrange.
Lowdoseregimenisbetter alternative tocontrolseizuresin eclampticpatients.
Keywords:
    eclampsia serummagnesium Primigravida
  • PDF (178 K)
  • XML
(2022). Comparative study of serum magnesium levels between low dose mgso4and Pritchard regimen in treatment of eclampsia. European Journal of Molecular & Clinical Medicine, 9(1), 736-741.
Dr.PeruguSravani,Dr. MahitaRaniKatasani,Dr. K. Sharada. "Comparative study of serum magnesium levels between low dose mgso4and Pritchard regimen in treatment of eclampsia". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 736-741.
(2022). 'Comparative study of serum magnesium levels between low dose mgso4and Pritchard regimen in treatment of eclampsia', European Journal of Molecular & Clinical Medicine, 9(1), pp. 736-741.
Comparative study of serum magnesium levels between low dose mgso4and Pritchard regimen in treatment of eclampsia. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 736-741.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 97
  • PDF Download: 119
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus